Profil
Roderike Pohl was Vice President-Research for Biodel, Inc. from December 2003 to December 13, 2008.
He was a Scientific Consultant for Steiner Ventures LLC from August 2003 to November 2003.
Dr. Pohl was Vice President of Preclinical Research MannKind Corporation from December 1998 to July 2003.
He received a PhD from the University of Connecticut.
Anciens postes connus de Roderike Pohl
| Sociétés | Poste | Fin |
|---|---|---|
Biodel, Inc.
 Biodel, Inc. Pharmaceuticals: MajorHealth Technology Biodel, Inc. is a pharmaceutical company, which develops novel formulations of already approved therapeutics to treat endocrine disorders such as diabetes and osteoporosis. The company develops product candidates by applying formulation technologies to existing drugs in order to improve their therapeutic profiles. Biodel was founded by Solomon S. Steiner and Erik Steiner on December 3, 2003 and is headquartered in Danbury, CT. | Directeur Technique/Scientifique/R&D | 13/12/2008 |
| Pharmaceutical Discovery Corp. | Directeur Technique/Scientifique/R&D | 01/07/2003 |
Formation de Roderike Pohl
| University of Connecticut | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Biodel, Inc.
Biodel, Inc. Pharmaceuticals: MajorHealth Technology Biodel, Inc. is a pharmaceutical company, which develops novel formulations of already approved therapeutics to treat endocrine disorders such as diabetes and osteoporosis. The company develops product candidates by applying formulation technologies to existing drugs in order to improve their therapeutic profiles. Biodel was founded by Solomon S. Steiner and Erik Steiner on December 3, 2003 and is headquartered in Danbury, CT. | Health Technology |
| Pharmaceutical Discovery Corp. | Health Technology |
